Zelluna doses first solid tumour patient with ZI-MA4-1 in the ZIMA-101 Phase 1 trial
Zelluna ASA (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, has announced that the first patient has […]
Paediatric, Teenagers and Young Adults Solid Tumours Study Day
A comprehensive overview of the solid tumours for professionals who look after children and young people. This study day is aimed at medical, nursing and allied healthcare professionals who have […]
Colorectal cancer gene implicated in broad range of solid tumours
A gene associated with colorectal cancer appears to also play a role in the development of other solid tumours, according to a study of over 350,000 patient biopsy samples conducted […]
Major collaborative childhood cancer research programme launched
Leading charities Children with Cancer UK and Cancer Research UK will co-fund a major £5.5 million research programme to advance precision medicine for children and young people whose cancer has returned. The […]
